查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609619

美国血液采集市场规模、份额、趋势分析报告：按地点、按应用、按最终用途、按年龄、按人口统计、细分市场预测，2025-2030 年

U.S. Blood Collection Market Size, Share & Trends Analysis Report By Site (Venous, Capillary), By Application (Diagnostics, Treatment), By End Use, By Age, By Demography, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

美国血液采集市场的成长与趋势：

Grand View Research, Inc. 的一项新研究显示，到 2030 年，美国血液采集市场预计将达到 20.8 亿美元。预计2025年至2030年该市场将以8.91%的复合年增长率成长。慢性病和感染疾病的增加、输血次数的增加以及血液疾病盛行率的上升主要推动了整体市场的成长。根据 CDC资料，到 2022 年，大约有 3,800 万成年人将患有糖尿病。此外，每年高达 53% 的新发生 2 型糖尿病病例与肥胖有关。因此，糖尿病盛行率的增加预计将推动重复诊断测试（例如血糖测量）对真空采血管的需求。

血液疾病的日益流行凸显了对真空采血器诊断这些疾病的需求，从而推动了对真空采血器的需求。例如，根据白血病和淋巴瘤协会的一份报告，大约每三分钟就有一个人被诊断出患有血癌。血液疾病负担的增加需要有效的血液采集方法来诊断和监测，从而推动血液采集市场的发展。

技术的进步使得血液采样市场更加先进和准确。此外，床边检测 (POCT) 解决方案在药房、紧急护理中心和医生办公室等各种医疗机构中的扩展可能会推动美国的血液采样需求。因此，社区药局正在扩大其在 POCT 中的作用，直接为美国，包括抽血。

美国血液收集市场报告亮点

  • 从地区来看，静脉领域占据市场主导地位，销售份额为82.44%。这是因为我们可以获得高品质样品的可靠性和效率。
  • 按最终用途划分，医院业以 28.01% 的销售份额占据市场主导地位。
  • 按年龄划分，19至65岁细分市场在2024年占据最大市场占有率，预计在预测期内将以最快的复合年增长率增长。
  • 预计城市细分市场将在 2024 年主导美国市场，并在预测期内以最快的复合年增长率成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章美国采血市场波动趋势及范围

  • 市场体系展望
    • 母市场
    • 辅助市场
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 美国血液采集市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 法律规范
    • 价格分析
    • 2024 年按主要国家和主要物种分類的预计动物数量
    • COVID-19 影响分析

第四章美国采血市场：位置估计与趋势分析

  • 细分仪表板
  • 美国采血市场：区域差异分析
  • 2018-2030 年美国采血市场规模及趋势分析（按地区）
  • 静脉
  • 微血管
    • 采血针
    • 微型容器管
    • 微量血球容积比管
    • 加温装置
    • 其他的

第五章美国采血市场：按应用估计和趋势分析

  • 细分仪表板
  • 美国采血市场：依用途分析波动
  • 2018-2030 年美国采血市场规模及趋势分析（依应用）
  • 诊断
  • 治疗

第六章美国血液采集市场：最终用途的估计与趋势分析

  • 细分仪表板
  • 美国血液采集市场：最终用途的波动分析
  • 2018-2030 年美国血液采集市场规模与趋势分析（依最终用途）
  • 医院
  • 临床实验室
  • 血库中心
  • 诊所
  • 行动服务
  • 急诊部
  • 其他的

第七章美国采血市场：依年龄分類的估计与趋势分析

  • 细分仪表板
  • 美国采血市场：依年龄组别变化分析
  • 2018-2030 年美国采血市场规模及趋势分析（按年龄）
    • 0-18岁
    • 19-65岁
    • 66岁以上

第八章美国采血市场：人口统计估计与趋势分析

  • 细分仪表板
  • 美国采血市场：人口变化分析
  • 2018-2030 年美国血液采集市场规模与趋势分析（按人口统计）
    • 城市
    • 农村

第9章 竞争格局

  • 市场参与企业分类
  • 企业市场分析/堆图分析
  • 公司简介
    • Sekisui Medical Co., Ltd.
    • Becton, Dickinson and Company（BD）
    • Greiner Bio-One
    • QIAGEN
    • Nipro Corporation
    • Terumo Corporation
    • Haemonetics Corp.
    • Zhejiang Gongdong Medical Technology Co., Ltd
    • Drucker Diagnostics
    • AdvaCare Pharma
  • 策略规划
    • 併购
    • 伙伴关係与协作
    • 扩张
    • 产品发布
    • 其他的
  • 其他主要企业名单
Product Code: GVR-4-68040-413-6

U.S. Blood Collection Market Growth & Trends:

The U.S. blood collection market size is expected to reach USD 2.08 billion by 2030, according to a new study by Grand View Research, Inc. The market is projected to grow at a CAGR of 8.91% from 2025 to 2030. The increasing prevalence of chronic and infectious diseases, growing number of blood transfusions, and rising prevalence of hematological disorders are primarily driving the overall market growth. As per CDC data, approximately 38 million adults were suffering from diabetes in 2022. In addition, obesity is linked to up to 53% of new type 2 diabetes cases annually. Thus, the increasing prevalence of diabetes is expected to boost the demand for vacutainers in recurring diagnostic tests, such as blood sugar assays.

The growing prevalence of hematological disorders highlights the need for vacutainers to diagnose these disorders, driving the demand for vacuum blood collection devices. For instance, the Leukemia & Lymphoma Society reports that approximately one person is diagnosed with blood cancer every 3 minutes. This increasing burden of hematological disorders necessitates effective blood collection methods for diagnosis and monitoring, thereby propelling the blood collection market.

The growing advancements in technology have made the blood collection market more sophisticated and accurate. Moreover, expansion of Point-of-Care Testing (POCT) solutions in various healthcare settings, including pharmacies, urgent care centers, and clinics, can drive the demand for blood collection in the U.S. Community pharmacies are increasingly playing a pivotal role in collection services, leveraging their accessibility and patient trust to enhance healthcare delivery. Thus, community pharmacies are expanding their role in POCT, offering convenient and accessible diagnostic services, including blood collection, directly to patients in the U.S.

U.S. Blood Collection Market Report Highlights:

  • Based on site, the venous segment dominated the market with a revenue share of 82.44%. owing to its reliability and efficiency in obtaining high-quality samples.
  • Based on end use, the hospitals segment dominated the market with a revenue share of 28.01%, owing to the high number of cases and diagnostic tests being conducted.
  • Based on age, the 19 to 65 segments accounted for the largest market share in 2024 and are expected to grow at the fastest CAGR over the forecast period
  • The urban segment dominated the U.S. market in 2024 and is expected to grow at the fastest CAGR over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Country Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Blood Collection Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Prevalence of Chronic and Infectious Diseases
      • 3.2.1.2. Growing Number of Blood Transfusions
      • 3.2.1.3. Rising Prevalence of Hematological Disorders
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Risks Associated with Blood Collection
      • 3.2.2.2. Stringent Regulations on Blood Collection
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. U.S. Blood Collection Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Pricing Analysis
    • 3.3.5. Estimated Animal Population, by key countries & Key species, 2024
    • 3.3.6. COVID-19 Impact Analysis

Chapter 4. U.S. Blood Collection Market: Site Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Blood Collection Market: Site Movement Analysis
  • 4.3. U.S. Blood Collection Market Size & Trend Analysis, by Site, 2018 to 2030 (USD Million) (Volume, Units Sold in Million)
  • 4.4. Venous
    • 4.4.1. Venous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
      • 4.4.1.1. Needles and Syringes
        • 4.4.1.1.1. Double-Ended Needles
        • 4.4.1.1.2. Winged Blood Collection Sets
        • 4.4.1.1.3. Standard Hypodermic Needles
        • 4.4.1.1.4. Other Blood Collection Needles
      • 4.4.1.2. Blood Collection Tubes
        • 4.4.1.2.1. Serum-separating tubes
        • 4.4.1.2.2. EDTA
        • 4.4.1.2.3. Heparin
        • 4.4.1.2.4. Plasma-separating
      • 4.4.1.3. Blood Bags
      • 4.4.1.4. Others
  • 4.5. Capillary
    • 4.5.1. Capillary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
    • 4.5.2. Lancets
    • 4.5.3. Micro-Container Tubes
    • 4.5.4. Micro-Hematocrit Tubes
    • 4.5.5. Warming Devices
    • 4.5.6. Others

Chapter 5. U.S. Blood Collection Market: By Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Blood Collection Market: By Application Movement Analysis
  • 5.3. U.S. Blood Collection Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million) (Volume, Units Sold in Million)
  • 5.4. Diagnostics
    • 5.4.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
  • 5.5. Treatment
    • 5.5.1. Treatment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)

Chapter 6. U.S. Blood Collection Market: By End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Blood Collection Market: By End Use Movement Analysis
  • 6.3. U.S. Blood Collection Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million) (Volume, Units Sold in Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
  • 6.5. Clinical Laboratories
    • 6.5.1. Clinical Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
  • 6.6. Blood Banks Centers
    • 6.6.1. Blood Banks Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
  • 6.7. Clinics
    • 6.7.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
  • 6.8. Mobile Service
    • 6.8.1. Mobile Service Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
  • 6.9. Emergency Departments
    • 6.9.1. Emergency Departments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
  • 6.10. , Others
    • 6.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)

Chapter 7. U.S. Blood Collection Market: By Age Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Blood Collection Market: By Age Movement Analysis
  • 7.3. U.S. Blood Collection Market Size & Trend Analysis, by Age, 2018 to 2030 (USD Million) (Volume, Units Sold in Million)
    • 7.3.1. 0-18
      • 7.3.1.1. 0-18 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
    • 7.3.2. 19 to 65
      • 7.3.2.1. 19 to 65 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
    • 7.3.3. 66 years and above
      • 7.3.3.1. 66 years and Above Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)

Chapter 8. U.S. Blood Collection Market: By Demography Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. U.S. Blood Collection Market: By Demographic Movement Analysis
  • 8.3. U.S. Blood Collection Market Size & Trend Analysis, by Demographic, 2018 to 2030 (USD Million) (Volume, Units Sold in Million)
    • 8.3.1. Urban
      • 8.3.1.1. Urban Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
    • 8.3.2. Rural
      • 8.3.2.1. Rural Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Position Analysis/ Heap Map Analysis
  • 9.3. Company Profiles
    • 9.3.1. Sekisui Medical Co., Ltd.
      • 9.3.1.1. Company overview
      • 9.3.1.2. Financial performance
      • 9.3.1.3. Product benchmarking
      • 9.3.1.4. Strategic initiatives
    • 9.3.2. Becton, Dickinson and Company (BD)
      • 9.3.2.1. Company overview
      • 9.3.2.2. Financial performance
      • 9.3.2.3. Product benchmarking
      • 9.3.2.4. Strategic initiatives
    • 9.3.3. Greiner Bio-One
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Product benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. QIAGEN
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Nipro Corporation
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Terumo Corporation
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Haemonetics Corp.
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Zhejiang Gongdong Medical Technology Co., Ltd
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Drucker Diagnostics
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. AdvaCare Pharma
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
  • 9.4. Strategy Mapping
    • 9.4.1. Mergers & Acquisitions
    • 9.4.2. Partnerships & Collaborations
    • 9.4.3. Expansion
    • 9.4.4. Product launch
    • 9.4.5. Others
  • 9.5. List of other Key players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Percentage of adults aged >=18 years with diagnosed heart disease, by age group and urbanization level in the U.S., in 2020
  • Table 3 Healthcare expenditures attributable to diabetes in the U.S., by demographic, in 2024
  • Table 4 Total blood donations by age in the U.S.
  • Table 5 Estimated new leukemia cancer cases and deaths by U.S. State, in 2024
  • Table 6 Blood collection fatalities in the U.S., October 2020-September 2021
  • Table 7 Percentage of population aged 65 or older in the U.S., in 2020
  • Table 8 U.S. blood collection market revenue estimates and forecast, by site, 2018 - 2030 (USD Million)
  • Table 9 U.S. blood collection market revenue estimates and forecast, by application, 2018 - 2030 (USD Million)
  • Table 10 U.S. blood collection market revenue estimates and forecast, by End Use, 2018 - 2030 (USD Million)
  • Table 11 U.S. blood collection market revenue estimates and forecast, by Age, 2018 - 2030 (USD Million)
  • Table 12 U.S. blood collection market revenue estimates and forecast, by Demography, 2018 - 2030 (USD Million)
  • Table 13 Company market share, 2024
  • Table 14 Key companies undergo other strategies.
  • Table 15 List of other players in Europe and MEA

List of Figures

  • Fig. 1 Blood collection market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Site and Application segment snapshot
  • Fig. 11 End use and age segment snapshot
  • Fig. 12 Demography segment snapshot
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Blood collection market value, 2023 (USD Billion)
  • Fig. 15 Market dynamics
  • Fig. 16 Number of red blood units transfused (in thousands) vs percent of supply in the U.S.
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTLE analysis
  • Fig. 19 U.S. blood collection market: Site outlook and key takeaways
  • Fig. 20 U.S. blood collection market: Site movement analysis
  • Fig. 21 Venous market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Venous market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 23 Needles and syringes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Needles and syringes market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 25 Double-ended needles market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Double-ended needles market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 27 Winged blood collection sets market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Winged blood collection sets market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 29 Standard hypodermic needles market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Standard hypodermic needles market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 31 Other blood collection needles market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Other blood collection needles market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 33 Blood collection tubes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Blood collection tubes market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 35 Serum-separating tubes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Serum-separating tubes market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 37 EDTA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 EDTA market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 39 Heparin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Heparin market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 41 Plasma-separating market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Plasma-separating market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 43 Blood bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Blood bags market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 45 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Others market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 47 Capillary market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Capillary market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 49 Lancets market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Lancets market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 51 Micro-container tubes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Micro-container tubes market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 53 Micro-hematocrit tubes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Micro-hematocrit tubes market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 55 Warming devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Warming devices market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 57 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Others market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 59 U.S. blood collection market: Application outlook and key takeaways
  • Fig. 60 U.S. blood collection market: Application movement analysis
  • Fig. 61 Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Diagnostics market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
  • Fig. 63 Treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Treatment market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
  • Fig. 65 U.S. blood collection market: End-use outlook and key takeaways
  • Fig. 66 U.S. blood collection market: End-use movement analysis
  • Fig. 67 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Hospitals market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
  • Fig. 69 Clinical laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Clinical laboratories market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
  • Fig. 71 Blood bank centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Blood bank centers market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
  • Fig. 73 Clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Clinics market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
  • Fig. 75 Mobile service market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Mobile service market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
  • Fig. 77 Emergency departments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Emergency departments market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
  • Fig. 79 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Others market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
  • Fig. 81 U.S. blood collection market: Age outlook and key takeaways
  • Fig. 82 U.S. blood collection market: Age movement analysis
  • Fig. 83 0-18 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 0-18 market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
  • Fig. 85 19-65 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 19-65 market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
  • Fig. 87 66 years and above market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 66 years and above market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
  • Fig. 89 U.S. blood collection market: Demography outlook and key takeaways
  • Fig. 90 U.S. blood collection market: Demography movement analysis
  • Fig. 91 Urban market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Urban market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
  • Fig. 93 Rural market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Rural market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
  • Fig. 95 U.S. blood collection market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 California blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 California blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 98 Previous year of percentage of adults with chances of developing cardiovascular disease in California and U.S., in 2022
  • Fig. 99 Texas blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Texas blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 101 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Texas and U.S.
  • Fig. 102 Florida blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 103 Florida blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 104 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Florida and U.S.
  • Fig. 105 New York blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 106 New York blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 107 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in New York and U.S.
  • Fig. 108 Pennsylvania blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 109 Pennsylvania blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 110 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Pennsylvania and U.S.
  • Fig. 111 Illinois blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 112 Illinois blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 113 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Illinois and U.S.
  • Fig. 114 Ohio blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 115 Ohio blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 116 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Ohio and U.S.
  • Fig. 117 Georgia blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 118 Georgia blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 119 Some blood establishments prepare a small amount of whole blood specifically for direct transfusion, in U.S., in 2022
  • Fig. 120 Percentage of population affected by chronic disease in Georgia, in 2023
  • Fig. 121 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Georgia and U.S.
  • Fig. 122 North Carolina blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 123 North Carolina blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 124 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in North Carolina and U.S.
  • Fig. 125 South Carolina blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 126 South Carolina blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 127 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in South Carolina and U.S.
  • Fig. 128 Michigan blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 129 Michigan blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 130 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Michigan and U.S.
  • Fig. 131 Alabama blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 132 Alabama blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 133 Arkansas blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 134 Arkansas blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 135 Kentucky blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 136 Kentucky blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 137 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Kentucky and U.S.
  • Fig. 138 Louisiana blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 139 Louisiana blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 140 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Louisiana and U.S.
  • Fig. 141 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Louisiana and U.S.
  • Fig. 142 Mississippi blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 143 Mississippi blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 144 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Mississippi and U.S.
  • Fig. 145 Tennessee blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 146 Tennessee blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 147 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Tennessee and U.S.
  • Fig. 148 West Virginia blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 149 West Virginia blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 150 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in West Virginia and U.S.
  • Fig. 151 Virginia blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 152 Virginia blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 153 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Virginia and U.S.
  • Fig. 154 Colorado blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 155 Colorado blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 156 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Colorado and U.S.
  • Fig. 157 Alaska blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 158 Alaska blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 159 Vermont blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 160 Vermont blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 161 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Vermont and U.S.
  • Fig. 162 South Dakota blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 163 South Dakota blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 164 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in South Dakota and U.S.
  • Fig. 165 Maine blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 166 Maine blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 167 Incidence: top 10 cancers, Maine 2020
  • Fig. 168 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Maine and U.S.
  • Fig. 169 Oregon blood collection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 170 Oregon blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
  • Fig. 171 Key company categorization